RNA-Binding Motif Protein 11 (RBM11) Serves as a Prognostic Biomarker and Promotes Ovarian Cancer Progression

Figure 1

RBM11 is overexpressed in ovarian cancer tissues and is highly associated with poor survival in ovarian cancer patients. (a) RBM11 mRNA expression in ovarian cancer tissues was assessed with TCGA database. (b, c) RRM1 protein levels in normal ovary and ovarian cancer tissue were analyzed by Immunohistochemistry (IHC) staining. Representative image of staining (b) and quantitative analysis of immunoscore (c) were provided. (d) Overall survival assay in ovarian cancer patients with high RBM11 mRNA level and low RBM11 mRNA level was performed using the Kaplan-Meier plotter online server (https://www.kmplot.com/analysis).

(a)

(b)

(c)

(d)